Lung Cancer

UCSF is a regional, national, and international referral center for lung cancer treatment. Research in lung cancer takes place in the Pulmonary Division, Medical Oncology, the Department of Surgery, the Helen Diller Comprehensive Cancer Center and ImmunoX. New initiatives related to Immuno-oncology including efforts to profile the immune environment in lung cancer are ongoing across these departments given the great promise of immunotherapy for lung cancer.

• Profiling of epithlelial and immune cells in lung cancer and pre-cancerous lesions. Yaron B. Gesthalter, MD

• Genetic & Immunological Mechanisms Driving Early-Stage, Surgically Resectable Thoracic Malignancies, Johannes Kratz Lab

• "systems genetics" in thoracic malignancies. David M. Jablons, M.D.

• Molecular basis of precision diagnosis and targeted therapy for lung cancer. Trever G. Bivona, MD, PhD

• Multi-level single cell characterization of immunity in the cancer microenvironment. http://immunoprofiler.org/